Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by AlexMachon Oct 06, 2017 11:31pm
101 Views
Post# 26788670

RE:RE:RE:RE:RE:RE:Too much garbage post here

RE:RE:RE:RE:RE:RE:Too much garbage post here
Grnhousegarbage wrote:
3) your comments hiding behind the adds (gotta love stockhouse) but I'll respond best I can. It's a great deal. What kind of business are you in? Have you ever watched that show the liquidator?...


Let me just put an end to this discussion. I'll show you how to properly look into this.

1. The Ebersbach Facility is about 400k sq.ft. for comparison Langton Ph1 is 217K with production of about 20,000kg of cannabis/yr or 20million grams per year. for simplification the Ebersbach should be around 37million grams per yr.

2. Weed in germany is about $12 euros to $20 euros per gram. lets take $12 euros for now. 

3. MARI targets low cost production of $1.34 cost per gram, say we double that because everything is more expensive in europe. thats 2.68 per gram. 

4. That streaming deal is for 20% of production at COST + 10%. so that's about $2.95 per gram. so the loss is [12-2.95] = $9.05

for the math: 20% of 37million grams = 7.4million grams x 9.05 per gram = roughly $67 euros. that's 22 million more than what they got from that deal. for 22million you can buy 6 more ebersbach facility. that's just bad deal. its like they sold their soul and future to the devil just so the stock is not diluted. If you take a more optimist assumption it just gets worse.

It looked good because its non-dilutive but in reality it was really bad for that company. ACB's management don't make those kind of mistakes. And for that I am fully convinced ACB's management is definitely better. I'd rather a diluted stock than a company managed like that.


Bullboard Posts